MAP - 5 (50 mg)This page contains information on MAP - 5 (50 mg) for veterinary use.
The information provided typically includes the following:
- MAP - 5 (50 mg) Indications
- Warnings and cautions for MAP - 5 (50 mg)
- Direction and dosage information for MAP - 5 (50 mg)
MAP - 5 (50 mg)This treatment applies to the following species:
Sterile Sodium Hyaluronate Cryopreservative (5 mg/mL)
Each vial contains: sodium hyaluronate 50.0 mg, sodium chloride USP 85.0 mg, sodium phosphate monobasic dihydrate 0.5 mg, sodium phosphate bibasic dodecahydrate 6.0 mg, water for injection USP q.s. 10 mL. Contains no preservatives. Store at 10-30°C.
Vetoquinol N.-A. Inc., Lavaltrie, QC, Canada
Vetoquinol USA, Inc., Fort Worth, TX, USA
NAC No.: 1005111.0
4250 N. SYLVANIA AVENUE, FORT WORTH, TX, 76137
|Every effort has been made to ensure the accuracy of the MAP - 5 (50 mg) information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-10-31